Cargando…

Comparative Analysis of Photon Stereotactic Radiotherapy and Carbon-Ion Radiotherapy for Elderly Patients with Stage I Non-Small-Cell Lung Cancer: A Multicenter Retrospective Study

SIMPLE SUMMARY: Surgery is the standard treatment for stage I non-small-cell lung cancer (NSCLC), but is often difficult to perform in elderly patients due to their comorbidities and inferior physical status. Stereotactic body radiotherapy (SBRT) is expected to be an alternative treatment and is bec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aoki, Shuri, Onishi, Hiroshi, Karube, Masataka, Yamamoto, Naoyoshi, Yamashita, Hideomi, Shioyama, Yoshiyuki, Matsumoto, Yasuo, Matsuo, Yukinori, Miyakawa, Akifumi, Matsushita, Haruo, Ishikawa, Hitoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377658/ https://www.ncbi.nlm.nih.gov/pubmed/37509294 http://dx.doi.org/10.3390/cancers15143633

Ejemplares similares

Clinical Outcomes of Stereotactic Body Radiotherapy for Patients With Stage I Small-Cell Lung Cancer: Analysis of a Subset of the Japanese Radiological Society Multi-Institutional SBRT Study Group Database
por: Shioyama, Yoshiyuki, et al.
Publicado: (2018)

Real-World Results of Stereotactic Body Radiotherapy for 399 Medically Operable Patients with Stage I Histology-Proven Non-Small Cell Lung Cancer
por: Onishi, Hiroshi, et al.
Publicado: (2023)

Survival outcomes after stereotactic body radiotherapy for 79 Japanese patients with hepatocellular carcinoma
por: Yamashita, Hideomi, et al.
Publicado: (2015)

Local effect of stereotactic body radiotherapy for primary and metastatic liver tumors in 130 Japanese patients
por: Yamashita, Hideomi, et al.
Publicado: (2014)

Case Series of 23 Patients Who Developed Fatal Radiation Pneumonitis After Stereotactic Body Radiotherapy for Lung Cancer
por: Onishi, Hiroshi, et al.
Publicado: (2018)

Stereotactic body radiotherapy (SBRT) for oligo-metastatic liver metastases from breast cancer, as an effective and safe alternative to surgery: a review
por: Aoki, Shuri, et al.
Publicado: (2020)

Stereotactic body radiotherapy in patients with lung tumors composed of mainly ground-glass opacity
por: Onishi, Hiroshi, et al.
Publicado: (2020)

Stereotactic Body Radiation Therapy for Patients with Pulmonary Interstitial Change: High Incidence of Fatal Radiation Pneumonitis in a Retrospective Multi-Institutional Study
por: Onishi, Hiroshi, et al.
Publicado: (2018)

Carbon-ion radiotherapy for patients with advanced stage non–small-cell lung cancer at multicenters
por: Karube, Masataka, et al.
Publicado: (2017)

Stereotactic body radiotherapy for centrally-located lung tumors with 56 Gy in seven fractions: A retrospective study
por: Aoki, Shuri, et al.
Publicado: (2018)

Factors related to primary cancer death and non‐primary cancer death in patients treated with stereotactic body radiotherapy for pulmonary oligometastases
por: Yamamoto, Takaya, et al.
Publicado: (2020)

Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: A Brief Overview
por: Matsuo, Yukinori
Publicado: (2023)

Linear accelerator-based stereotactic body radiation therapy in the treatment of oligometastatic disease
por: Yamashita, Hideomi, et al.
Publicado: (2020)

Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules?
por: Shibamoto, Yuta, et al.
Publicado: (2016)

Stereotactic Radiotherapy for Oligometastases in Lymph Nodes—A Review
por: Matsushita, Haruo, et al.
Publicado: (2018)

A Systematic Literature Review on Salvage Radiotherapy for Local or Regional Recurrence After Previous Stereotactic Body Radiotherapy for Lung Cancer
por: Matsuo, Yukinori
Publicado: (2018)

Renal atrophy after stereotactic body radiotherapy for renal cell carcinoma
por: Yamamoto, Takaya, et al.
Publicado: (2016)

Final report of survival and late toxicities in the Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer (JCOG0702)
por: Onimaru, Rikiya, et al.
Publicado: (2018)

Impact of pre-treatment C-reactive protein level and skeletal muscle mass on outcomes after stereotactic body radiotherapy for T1N0M0 non-small cell lung cancer: a supplementary analysis of the Japan Clinical Oncology Group study JCOG0403
por: Matsuo, Yukinori, et al.
Publicado: (2021)

Organizing pneumonia after stereotactic ablative radiotherapy of the lung
por: Murai, Taro, et al.
Publicado: (2012)

Stereotactic Body Radiotherapy for Small Lung Tumors in the University of Tokyo Hospital
por: Yamashita, Hideomi, et al.
Publicado: (2014)

Salvage stereotactic body radiotherapy for post-operative oligo-recurrence of non-small cell lung cancer: A single-institution analysis of 59 patients
por: Aoki, Shuri, et al.
Publicado: (2020)

Similar-Case-Based Optimization of Beam Arrangements in Stereotactic Body Radiotherapy for Assisting Treatment Planners
por: Magome, Taiki, et al.
Publicado: (2013)

Intractable Pleural Effusion After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer
por: Katano, Atsuto, et al.
Publicado: (2023)

Lung stereotactic radiotherapy for oligometastases: comparison of oligo-recurrence and sync-oligometastases†
por: Yamashita, Hideomi, et al.
Publicado: (2016)

Analyses of the local control of pulmonary Oligometastases after stereotactic body radiotherapy and the impact of local control on survival
por: Yamamoto, Takaya, et al.
Publicado: (2020)

Stereotactic Body Radiotherapy for Metastatic Lung Cancer as Oligo-Recurrence: An Analysis of 42 Cases
por: Takahashi, Wataru, et al.
Publicado: (2012)

Feasibility of carbon‐ion radiotherapy for re‐irradiation of locoregionally recurrent, metastatic, or secondary lung tumors
por: Hayashi, Kazuhiko, et al.
Publicado: (2018)

Stereotactic Radiotherapy for Pulmonary Oligometastases From Colorectal Cancer: A Systematic Review and Meta-Analysis
por: Jingu, Keiichi, et al.
Publicado: (2018)

Analyses of local control and survival after stereotactic body radiotherapy for pulmonary oligometastases from colorectal adenocarcinoma
por: Yamamoto, Takaya, et al.
Publicado: (2020)

Clinical results of stereotactic body radiotherapy for Stage I small-cell lung cancer: a single institutional experience
por: Shioyama, Yoshiyuki, et al.
Publicado: (2013)

Effects of two different radiotherapies for craniopharyngiomas using stereotactic radiosurgery/ stereotactic radiotherapy or fractionated stereotactic radiotherapy
por: Kamogawa, Misaki, et al.
Publicado: (2022)

Stereotactic Radiosurgery and Stereotactic Radiotherapy for Malignant Skull Base Tumors
por: Mori, Yoshimasa, et al.
Publicado: (2020)

Quality of life after definitive linear accelerator-based stereotactic radiotherapy for prostate cancer: a longitudinal study
por: Yamashita, Hideomi, et al.
Publicado: (2022)

Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer
por: Hayashi, Kazuhiko, et al.
Publicado: (2017)

Neuroendocrine Carcinoma of Uterine Cervix: Stereotactic Radiotherapy for Brain Metastasis and Stereotactic Body Radiotherapy for Renal and Pancreatic Metastases
por: Mori, Yoshimasa, et al.
Publicado: (2020)

Stereotactic Body Radiotherapy for Localized Ureter Transitional Cell Carcinoma: Three Case Reports
por: Maehata, Yoshiyasu, et al.
Publicado: (2015)

Changes in volume of stage I non-small-cell lung cancer during stereotactic body radiotherapy
por: Tatekawa, Kotoha, et al.
Publicado: (2014)

Feasibility Study of Automated Framework for Estimating Lung Tumor Locations for Target-Based Patient Positioning in Stereotactic Body Radiotherapy
por: Yoshidome, Satoshi, et al.
Publicado: (2015)

Percutaneous fiducial marker placement under CT fluoroscopic guidance for stereotactic body radiotherapy of the lung: an initial experience
por: Ohta, Kengo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_19jrsiudfep1dsalq378kskeel